Labeler
Fresenius Kabi USA, LLC NDC Codes
Fresenius Kabi USA, LLC lists 714 finished drug products in the FDA NDC Directory under NDC labeler codes 63323, 65219, 76045.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Tyenne, Rocuronium, Sodium chloride, Dextrose, Otulfi, ketamine hydrochloride, Sterile Water, Levetiracetam, Cyclophosphamide, Vitalipid N, Ustekinumab-Aauz, Sodium Bicarbonate, ephedrine sulfate, Bomyntra, Succinylcholine Chloride
- Active ingredients
- Tocilizumab, Ustekinumab, Rocuronium bromide, Sodium chloride, Dextrose monohydrate, Phytonadione, Ketamine hydrochloride, Water, Levetiracetam, Denosumab, Cyclophosphamide, Vitamin a palmitate
- NDC labeler codes
- 63323, 65219, 76045
- Strengths (from the 100 most recently listed products)
- Rocuronium bromide 10 mg/mL; Dextrose monohydrate 50 mg/mL; Tocilizumab 162 mg/.9mL; Water 1 mL/mL; Sodium chloride .9 g/100mL; Ustekinumab 45 mg/.5mL; Ustekinumab 90 mg/mL; Ephedrine sulfate 5 mg/mL; Denosumab 70 mg/mL; Succinylcholine chloride dihydrate 20 mg/mL; Diphenhydramine hydrochloride 50 mg/mL; Amiodarone hydrochloride 50 mg/mL; Epinephrine 1 mg/mL; Chlorpromazine hydrochloride 25 mg/mL; Acyclovir sodium 50 mg/mL; Lorazepam 2 mg/mL; Gadobutrol 604.72 mg/mL; Desmopressin acetate 4 ug/mL; Vitamin a palmitate 230 [iU]/mL; Ergocalciferol 40 [iU]/mL
- Dosage forms
- Injection, Solution, Injection, Injection, Solution, Concentrate, Kit, Injection, Powder, For solution, Emulsion, Injection, Emulsion, Injection, Powder, Lyophilized, For solution, Solution
- Routes
- Intravenous, Subcutaneous, Intramuscular, Irrigation, Oral, Epidural, Infiltration, Perineural, Intraocular
- Drug classes (FDA established)
- Osmotic Laxative, Interleukin-6 Receptor Antagonist, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Potassium Salt, Nondepolarizing Neuromuscular Blocker, General Anesthetic, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Vitamin K, Warfarin Reversal Agent, RANK Ligand Inhibitor, Benzodiazepine, Provitamin D2 Compound, Vitamin A, Norepinephrine Releasing Agent, Depolarizing Neuromuscular Blocker, Histamine-1 Receptor Antagonist, Antiarrhythmic, Catecholamine, Phenothiazine, Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Opioid Antagonist, Gadolinium-based Contrast Agent, Factor VIII Activator, Vasopressin Analog, alpha-1 Adrenergic Agonist, Vitamin C, Paramagnetic Contrast Agent, Lipoglycopeptide Antibacterial, Heparin Reversal Agent, beta-Adrenergic Blocker, Amide Local Anesthetic, Calcitonin, Antifibrinolytic Agent, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Proton Pump Inhibitor, Oxytocic, Corticosteroid, Anticholinergic
- HCPCS / J-code
- J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg, J0897 — Injection, denosumab, 1 mg, J0171 — Injection, adrenalin, epinephrine, 0.1 mg
- Package NDCs
- 108 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Xylocainelidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 5 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionInfiltration, Perineural | 63323-481 | 63323-0481-57 | — |
| Xylocainelidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .01 mg/mL | Injection, SolutionInfiltration, Perineural | 63323-482 | 63323-0482-26 | — |
| Xylocainelidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .01 mg/mL | Injection, SolutionInfiltration, Perineural | 63323-482 | 63323-0482-1763323-0482-2763323-0482-57 | — |
| Xylocainelidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL | Injection, SolutionInfiltration, Perineural | 63323-483 | 63323-0483-2763323-0483-57 | — |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 5 mg/mL | Injection, SolutionInfiltration, Perineural | 63323-484 | 63323-0484-57 | — |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionInfiltration, Perineural | 63323-485 | 63323-0485-26 | — |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionInfiltration, Perineural | 63323-485 | 63323-0485-2763323-0485-57 | — |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionInfiltration, Perineural | 63323-486 | 63323-0486-26 | — |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionInfiltration, Perineural | 63323-486 | 63323-0486-1763323-0486-2763323-0486-57 | — |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 63323-487 | 63323-0487-1763323-0487-3163323-0487-37 | — |
| Xylocaine MPFlidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 15 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 63323-488 | 63323-0488-1763323-0488-3163323-0488-37 | — |
| Xylocaine MPFlidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 63323-489 | 63323-0489-1763323-0489-2163323-0489-27 | — |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 5 mg/mL | Injection, SolutionInfiltration | 63323-491 | 63323-0491-57 | — |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 63323-492 | 63323-0492-1663323-0492-2663323-0492-36 | — |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 63323-492 | 63323-0492-2763323-0492-3163323-0492-37+1 more | — |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 63323-495 | 63323-0495-26 | — |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | 63323-495 | 63323-0495-0763323-0495-27 | — |
| Ganciclovirganciclovir sodium | Ganciclovir sodium 500 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-315 | 63323-0315-10 | — |
| Ganciclovirganciclovir sodium | Ganciclovir sodium 500 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-315 | 63323-0315-94 | — |
| Lidocainelidocaine hydrochloride | Lidocaine hydrochloride 10 mg/mL | Injection, SolutionInfiltration, Perineural | 63323-201 | 63323-0201-0263323-0201-10 | — |
| Lidocainelidocaine hydrochloride | Lidocaine hydrochloride 20 mg/mL | Injection, SolutionInfiltration, Perineural | 63323-202 | 63323-0202-02 | — |
| Indomethacin | Indomethacin 1 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-659 | 63323-0659-03 | — |
| Indomethacin | Indomethacin 1 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-659 | 63323-0659-94 | — |
| Indomethacin | Indomethacin 1 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 63323-659 | 63323-0659-09 | — |
| Deferoxaminedeferoxamine mesylate | Deferoxamine mesylate 95 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous, Subcutaneous | 63323-597 | 63323-0597-10 | — |
| Deferoxaminedeferoxamine mesylate | Deferoxamine mesylate 95 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous, Subcutaneous | 63323-599 | 63323-0599-30 | — |
| Fosphenytoinfosphenytoin sodium | Fosphenytoin sodium 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | 63323-403 | 63323-0403-0263323-0403-10 | — |
| Rocuroniumrocuronium bromide | Rocuronium bromide 10 mg/mL | Injection, SolutionIntravenous | 63323-426 | 63323-0426-15 | — |
| Rocuroniumrocuronium bromide | Rocuronium bromide 10 mg/mL | Injection, SolutionIntravenous | 63323-426 | 63323-0426-0563323-0426-10 | — |
| Carboplatin | Carboplatin 10 mg/mL | Injection, SolutionIntravenous | 63323-172 | 63323-0172-60 | — |
| Colistimethatecolistimethate sodium | Colistimethate sodium 150 mg/2mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 63323-393 | 63323-0393-06 | — |
| Granisetrongranisetron hydrochloride | Granisetron hydrochloride 1 mg/mL | Injection, SolutionIntravenous | 63323-318 | 63323-0318-01 | — |
| Caffeine Citrate | Caffeine citrate 20 mg/mL | SolutionOral | 63323-406 | 63323-0406-03 | — |
| Caffeine Citrate | Caffeine citrate 20 mg/mL | Injection, SolutionIntravenous | 63323-407 | 63323-0407-03 | — |
| Caffeine Citrate | Caffeine citrate 20 mg/mL | Injection, SolutionIntravenous | 63323-407 | 63323-0407-04 | — |
| Ondansetronondansetron hydrochloride | Ondansetron hydrochloride 2 mg/mL | InjectionIntramuscular, Intravenous | 65219-323 | 65219-0323-02 | J2405 |
| Ondansetronondansetron hydrochloride | Ondansetron hydrochloride 2 mg/mL | InjectionIntramuscular, Intravenous | 63323-373 | 63323-0373-02 | J2405 |
| Ondansetronondansetron hydrochloride | Ondansetron hydrochloride 2 mg/mL | InjectionIntramuscular, Intravenous | 63323-374 | 63323-0374-20 | J2405 |
| Cefotetancefotetan disodium | Cefotetan disodium 1 g/10mL | Injection, Powder, For solutionIntramuscular, Intravenous | 63323-385 | 63323-0385-10 | — |
| Cefotetancefotetan disodium | Cefotetan disodium 2 g/20mL | Injection, Powder, For solutionIntramuscular, Intravenous | 63323-386 | 63323-0386-20 | — |
| Diprivanpropofol | Propofol 10 mg/mL | Injection, EmulsionIntravenous | 63323-269 | 63323-0269-1663323-0269-3763323-0269-57+1 more | — |
| Polymyxin Bpolymyxin b sulfate | Polymyxin b sulfate 500000 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intrathecal, Intravenous, Ophthalmic | 63323-321 | 63323-0321-10 | — |
| Polymyxin Bpolymyxin b sulfate | Polymyxin b sulfate 500000 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intrathecal, Intravenous, Ophthalmic | 63323-321 | 63323-0321-12 | — |
| Diprivanpropofol | Propofol 10 mg/mL | Injection, EmulsionIntravenous | 63323-269 | 63323-0269-5963323-0269-6963323-0269-94 | — |
| Diprivanpropofol | Propofol 10 mg/mL | Injection, EmulsionIntravenous | 63323-269 | 63323-0269-7063323-0269-7763323-0269-78 | — |
| Diprivanpropofol | Propofol 10 mg/mL | Injection, EmulsionIntravenous | 63323-269 | 63323-0269-1063323-0269-2963323-0269-50+1 more | — |
| Aztreonam | Aztreonam 1 g/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 63323-401 | 63323-0401-26 | — |
| Aztreonam | Aztreonam 1 g/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 63323-401 | 63323-0401-24 | — |
| Aztreonam | Aztreonam 1 g/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 63323-401 | 63323-0401-20 | — |
| Aztreonam | Aztreonam 2 g/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 63323-402 | 63323-0402-30 | — |
Fresenius Kabi USA, LLC: common questions
- What is Fresenius Kabi USA, LLC's NDC labeler code?
- 63323, 65219, 76045. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Fresenius Kabi USA, LLC?
- Med-Code's HCPCS directory matches J3357, J0897, J0171 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.